论文部分内容阅读
目的 回顾性总结无水酒精瘤内注射治疗肝癌的疗效。方法 采用B超普通探头引导经皮肝穿刺瘤内注射无水酒精 (PEIT)治疗原发性、转移性肝癌 68例 ,共治疗 492次。结果 直径 <5cm肿瘤缩小率为 71.1% ,>5cm肿瘤缩小率 65 .5 % ;甲胎蛋白阳性病人下降率占 92 .3 % ,转阴率 2 0 .4% ;病人 1、2、3年生存率分别为 5 8.3 %、3 2 .4%、12 % ;联合肝动脉化疗栓塞病人生存期比非联合的长 ;全组病人无一例发生与该治疗有关的严重并发症。结论 该法具有适应症广、疗效确切、创伤小、操作简易、便于推广等优点。联合肝动脉化疗栓塞可提高疗效
Objective To retrospectively summarize the efficacy of intra-arterial injection of anhydrous alcohol in the treatment of liver cancer. Methods A total of 68 cases of primary and metastatic liver cancer were treated with B ultrasound probe guided percutaneous transhepatic intratumoral injection of anhydrous alcohol (PEIT) for 492 times. Results The diameter reduction of tumor was 71.1% and the rate of tumor shrinkage was 65.5%> 5 cm in diameter. The decline rate of α-fetoprotein positive patients was 92.3% and the rate of negative conversion was 20.4%. The patients were 1, 2 and 3 years Survival rates were 5.33%, 32.4% and 12%, respectively. The survival rate of the patients with combined chemoembolization of the hepatic artery was longer than that of the non-combined patients. None of the patients in the whole group had serious complications associated with the treatment. Conclusion The method has the advantages of broad indications, curative effect, small trauma, simple operation, easy to promote and so on. Combined hepatic artery chemoembolization can improve the curative effect